Jasneet Singh

Also affiliated with Advanced Energy (United States), Access to Wholistic and Productive Living Institute, Access to Advanced Health Institute, Punjab Agricultural University

Biochemistry, Genetics and Molecular BiologyAgricultural and Biological SciencesEnergy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Intranasal self-amplifying RNA SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission”.

Intranasal self-amplifying RNA SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.10.515993

N/A

0.360DataRank · unranked

10 citations

Michael D. Schultz, Samuel Beaver, Peter Battisti, Julie Bakken, Derek Hanson +22 more

An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114054

N/A

0.330DataRank · unranked

8 citations

Devin S. Brandt, Madeleine F. Jennewein, Jasneet Singh, Samuel Beaver, Matthew R. Ykema +14 more

A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.31.635934

N/A

0.104DataRank · unranked

1 citations

Matthew Ykema, Darshan N. Kasal, Madeleine F. Jennewein, Samuel Beaver, Abbie E. Weight +12 more

Development of an Intranasally- and Intramuscularly-Administrable Replicon Vaccine Efficacious Against H5N1 Influenza Virus

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.03.31.646478

N/A

0.104DataRank · unranked

1 citations

Devin S. Brandt, Madeleine F. Jennewein, Jasneet Singh, Samuel Beaver, Matthew Ykema +14 more

Intranasal replicon SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission

Molecular Therapy(2025)10.1016/j.ymthe.2025.04.007

N/A

0DataRank · unranked

12 citations

Michael D. Schultz, Samuel Beaver, Peter Battisti, Julie Bakken, Derek Hanson +22 more

The ID93 + GLA-3M-052-LS vaccine candidate elicits mucosal and systemic immunogenicity and protective efficacy against Mycobacterium tuberculosis challenge in BCG-primed Collaborative Cross inbred mice

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.31.685426

N/A

0DataRank · unranked

1 citations

Anas Alsharaydeh, Darshan N. Kasal, Madeleine F. Jennewein, Devin S. Brandt, Susan Lin +8 more

An intranasal, NLC-delivered self-amplifying RNA vaccine establishes protective immunity against pre-pandemic H5N1 and H7N9 influenza

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.07.631792

N/A

0DataRank · unranked

5 citations

Michael A. Davis, Darshan N. Kasal, Madeleine F. Jennewein, Eric Lo, Jasneet Singh +13 more